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Carbazole derivatives are well known for their pharmacological activities. Several
reports have appeared on the syntheses of carbazole derivatives in connection with the
search for newer physiologically active compounds. Carbazomycin A and carbazomycin
B have been found to be useful antibacterial and antifungal agents (1, 2). It has been re-
ported that pyridocarbazoles show marked anticancer and anti-HIV activities (3–13).
The discovery of the antineoplastic activity of the naturally occurring alkaloid ellipticine
and its isomer olivacine has stimulated considerable research efforts in the field of con-
densed systems (14). In the present investigation, the Mannich reactions of 1-oxo-1,2,3,4-
-tetrahydrocarbazole ended up in the formation of N,N’-bis(1,2,3,4-tetrahydrocarbazol-
-1-ylidene) ethane-1,2-diamines (2) and 2-[{1-(2-(2-aminoethoxy)ethylimino)-1,2,3,4-tet-
rahydrocarbazol-2-yl methyl}amino] ethanols (3).
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The reaction of 1-oxo-1,2,3,4-tetrahydrocarbazoles (1a–e)
with paraformaldehyde and ethylenediamine yielded N,N’-
-bis(1,2,3,4-tetrahydrocarbazol-1-ylidene)ethane-1,2-dia-
mines (2a–e). Here, like in another similar attempt of re-
placing ethylenediamine by ethanolamine, ended up in
formation of 2-{[1-(2-(2-aminoethoxy)ethylimino)-1,2,3,4-
-tetrahydrocarbazol-2-yl-methyl]amino} ethanols (3a–e).
These products were characterized by IR, 1H NMR, mass
spectra and by elemental analysis. All end products (2a–e,
3a–e) were screened for antibacterial and antifungal ac-
tivities. The compounds having substituents at C-6 posi-
tion were found to exhibit pronounced antimicrobial ac-
tivities.
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hyde, ethylenediamine, ethanolamine, N,N’-bis(1,2,3,4-tetra-
hydrocarbazol-1-ylidene)ethane-1,2-diamine, 2-{[1-(2-(2-
aminoethoxy)ethylimino)-1,2,3,4-tetrahydrocarbazol-2-yl-
methyl]-amino}ethanol, antibacterial, antifungal activity
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EXPERIMENTAL
Melting points were determined using a Mettler FP 51 apparatus (Mettler Instruments,
Switzerland) and were uncorrected. IR spectra were recorded using KBr on a Shimadzu
FTIR-8201PC spectrophotometer (Shimadzu, Japan). 1H NMR spectra were recorded in
CDCl3 on a Varian AMX 400 FT-NMR (Varian Australia, Australia) using tetramethyl-
silane as internal standard. Mass spectra were recorded on a Jeol-JMS-D-300 mass spec-
trometer (70 eV) (Jeol, Japan). Microanalyses were done on a Perkin Elmer Model 240
CHN analyzer (Perkin-Elmer, USA). The purity of the products was tested by TLC using
glass plates coated with silica gel G (HiMedia Laboratories, India) and petroleum ether
and ethyl acetate (85:15) as the developing solvents.
Synthesis of N,N’-bis(1,2,3,4-tetrahydrocarbazol-1-ylidene)ethane-1,2-diamines (2).
General method
A mixture of the appropriate 1-oxo-1,2,3,4-tetrahydrocarbazole 1 (0.001 mol), para-
formaldehyde (0.001 mol) and ethylenediamine (10 mL) was heated on oil bath at 120 °C
for 3 h. The reaction was monitored by TLC and after the completion of the reaction the
mixture was poured into crushed ice, filtered, dried and recrystallized using ethanol to
yield N,N’-bis(1,2,3,4-tetrahydrocarbazol-1-ylidene)ethane-1,2-diamine (2) (Tables I and II).
Synthesis of 2-{[1-(2-(2-aminoethoxy)ethylimino)-1,2,3,4-tetrahydrocarbazol-2-yl-
-methyl]amino}ethanols (3). General method
A mixture of the relevant 1-oxo-1,2,3,4-tetrahydrocarbazole 1 (0.001 mol), paraform-
aldehyde (0.001 mol) and ethanolamine (10 mL) was heated on oil bath at 120 °C for 3 h.
The reaction was monitored by TLC. After the completion of the reaction, the mixture
was poured into crushed ice, filtered, dried and recrystallized using ethanol to yield 2-{[1-
-(2-(2-aminoethoxy)ethylimino)-1,2,3,4-tetrahydrocarbazol-2-yl-methyl]amino}-ethanol (3)
(Tables I and II).
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Elemental analysis (%) Calcd./found
C H N
2a 65 116–118 C28H30N4 (422.25) 79.59/79.21 7.16/7.30 13.26/13.20
2b 67 139–142 C28H30N4 (422.25) 79.59/79.97 7.16/7.07 13.26/12.99
2c 60 150–153 C28H30N4 (422.25) 79.59/80.77 7.16/6.98 13.26/12.75
2d 70 165–168 C26H24Cl2N4 (462.14) 67.39/67.10 5.22/5.37 12.09/12.19
2e 55 120–123 C26H26N4 (394.22) 79.16/78.75 6.64/6.95 14.20/14.43
3a 80 140–143 C20H30N4O2 (358.24) 67.01/67.97 8.44/8.27 15.63/15.30
3b 72 147–150 C20H30N4O2 (358.24) 67.01/67.63 8.44/8.17 15.63/15.45
3c 74 140–143 C20H30N4O2 (358.24) 67.01/67.11 8.44/8.58 15.63/15.71
3d 68 152–155 C19H27ClN4O2 (378.18) 60.23/59.07 7.18/7.23 14.79/15.06
3e 75 138–141 C19H28N4O2 (344.22) 66.25/65.60 8.19/8.44 16.27/16.03
Antibacterial studies
Newly synthesized compounds 2a–e and 3a–e were screened for their in vitro anti-
bacterial activity against Escherichia coli (ATCC 10536), Staphylococcus aureus (ATCC 6538),
Pseudomonas aeruginosa (ATCC 9027) and Bacillus subtilis (ATCC 6633) according to the
disc diffusion method (15). The minimum inhibitory concentration (MIC) was determin-
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Table II. IR, 1H NMR and mass spectral data for compounds 2a–e and 3a–e
Compd.
No
IR (n, cm–1) 1H NMR signals (d, ppm)
MS
(m/z)
2a 3411, 3275, 2922,
1630, 1614, 1445
11.44, 10.83 (2 b s, 2H, N9-, N9’-H), 7.10–7.50 (m, 4H,
C7-, C8-,C7’-,C8’-H), 6.97, 6.95 (2s, 2H, C5, C5’-H), 2.39,
2.35 (2 s, 6H, C6-, C6’-CH3), 1.87-3.94 (m, 16H, eight CH2)
422
2b 3420, 3287, 2924,
1641, 1624, 1464
11.47–10.98 (2 b s, 2H, N9-, N9’-H), 7.56, 7.54 (2 s, 2H,
C8, C8’-H), 6.65–7.43 (m, 4H, C5-, C6-,C5’-,C6’-H), 2.41,
2.38 (2 s, 6H, C7-, C7’-CH3), 1.90–3.60 (m, 16H, eight CH2)
422
2c 3414, 3306, 2924,
1630, 1607, 1450
11.44–11.60 (m, 2H, N9-, N9’-H), 6.85–7.55 (m, 6H, C5-,
C6-, C7-, C5’-, C6’-, C7’-H), 2.50, 2.49 (2 s, 6H, C8-, C8’-CH3),
1.82–4.00 (m, 16H, eight CH2)
422
2d 3411, 3275, 2922,
1646, 1613, 1462
11.00–11.35 (m, 2H, N9-, N9’-H), 7.07–7.79 (m, 4H, C7-,
C8-, C7’-, C8’-H), 6.97, 6.95 (2 s, 2H, C5, C5’-H), 1.69–4.17
(m, 16H, eight CH2)
462
2e 3412, 3240, 2926,
1630, 1607, 1447
11.55,10.96 (2 b s, 2H, N9-, N9’-H), 6.93–7.55 (m, 8H, C5-,





11.40 (b s, 1H, N9-H), 7.44 (s, 1H, C5-H), 7.25–7.30 (d,
1H, C8-H, J = 8.44 Hz), 7.12–7.17 (d, 1H, C7-H, J = 8.44
Hz), 4.40 (s, 1H, OH), 2.81–3.78 (m, 6H, three CH2-O),
2.39 (s, 3H, C6-CH3), 2.24–2.53 (m, 16H, C2-H, C3-H2,




13.42 (b s, 1H, N9-H), 7.16–7.57 (m, 3H, C5-, C6-,C8-H),
4.05 (s, 1H, OH), 2.22–3.43 (m, 22H, C2-H, C3-H2, C4-H2,




11.79 (b s, 1H, N9-H), 7.78–7.87 (d, 1H, C5-H, J = 7.96
Hz), 7.39–7.47 (d, 1H, C7-H, J=6.88 Hz), 7.29–7.37 (m,
1H, C6-H), 3.84 (s, 1H, OH), 2.78–3.68 (m, 22H, C2-H,




11.75 (b s, 1H, N9-H), 7.43 (s, 1H, C5-H), 7.31–7.34 (d,
1H, C8-H, J = 8.44 Hz), 7.28–7.30 (d, 1H, C7-H, J = 8.44
Hz), 4.38 (s, 1H, OH), 2.83–4.08 (m, 6H, three CH2-O),





11.50 (b s, 1H, N9-H), 7.64–7.72 (d, 1H, C8-H, 8.00 Hz),
7.37–7.44 (d, 1H, C5-H, J=8.28 Hz), 7.27–7.35 (m, 1H,
C7-H), 7.05–7.12 (m, 1H, C6-H), 4.37 (s, 1H, OH), 3.46–3.79
(m, 6H, three CH2-O), 2.24–3.02 (m, 16H, C2-H, C3-H2,
C4-H2, four CH2-N, NH, NH2)
344
ed by the serial dilution technique using dimethylsulphoxide as a solvent. Ciprofloxacin
(1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid)
was used as a standard in these antibacterial screening studies. The results are presented
in Table III.
Antifungal studies
The antifungal screening studies of compounds 2a–e and 3a–e were performed by
the standard agar disc diffusion method (16). Seven days old cultures of Aspergillus niger
(ATCC 16404), Candida albicans (ATCC 10231), Altenaria macrospora and Fusarium oxysporum
(isolated from rotten fruits) were used as test organisms. They were grown on a potato
dextrose agar medium. The MIC values were determined by the serial dilution techni-
que using dimethylsulphoxide as solvent. The growth of microorganisms was determined
visually and the lowest concentration that inhibited the growth of the microorganisms
for 24 hours at 37 °C was taken as the MIC. The standard used for comparison in anti-
fungal screening studies was carbendazim (1H-benzimadazol-2-yl carbamic acid methyl
ester). The results are presented in Table III.
Solutions of the standards, ciprofloxacin and carbendazim, were prepared in dime-
thylsulphoxide. A control experiment with dimethylsulphoxide alone was also done for
both the antibacterial and antifungal studies.
RESULTS AND DISCUSSION
The reaction of 1-oxo-1,2,3,4-tetrahydrocarbazoles (1a–e) (17) with paraformaldehyde
and ethylenediamine ended up in the formation of N,N’-bis(1,2,3,4-tetrahydrocarbazol-
-1-ylidene)ethane-1,2-diamines (2a–e) (Scheme 1). On the other hand, the treatment of
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Table III. Antimicrobial activity data of compounds 2a–e and 3a–e






















S. aureus 12.5 100.0 50.0 6.0 50.0 12.5 75.0 25.0 6.0 100.0 6.0
P. aeruginosa 25.0 150.0 50.0 12.5 100.0 12.5 50.0 50.0 25.0 100.0 12.5
E. coli 12.5 150.0 50.0 12.5 100.0 25.0 100.0 100.0 12.5 200.0 6.0









A. macrospora 12.5 100.0 100.0 12.5 100.0 25.0 100.0 150.0 12.5 150.0 6.0
C. albicans 25.0 150.0 50.0 6.0 200.0 25.0 200.0 100.0 6.0 150.0 6.0
A. niger 25.0 150.0 100.0 50.0 200.0 100.0 100.0 150.0 25.0 100.0 25.0
F. oxysporum 25.0 100.0 50.0 12.5 200.0 25.0 50.0 200.0 50.0 150.0 12.5
DMSO – negative control
a Referent standard ciprofloxacin
b Referent standard carbendazim
1-oxo-1,2,3,4-tetrahydrocarbazoles (1a–e) with paraformaldehyde and ethanolamine yielded
2-{[1-(2-(2-aminoethoxy)ethylimino)-1,2,3,4-tetrahydrocarbazol-2-yl-methyl]-amino}-etha-
nols (3a–e) (Scheme 2).
In our present investigation, the mixture of 6-methyl-1-oxo-1,2,3,4-tetrahydrocarba-
zole (1a), paraformaldehyde and ethylenediamine was heated at 120 °C for 3 h to afford
product 2a. Its IR spectrum (Table II) showed two bands at 3410 and 3275 cm–1 for two
NH stretching vibrations. Two strong vibrations at 1630 and 1614 cm–1 were due to C=N
stretchings. Its 1H NMR spectrum (Table II) showed the presence of two methyl groups
as two singlets at d 2.35 and d 2.39. The multiplets between d 1.87–3.94 showed the pres-
ence of eight aliphatic protons. Two singlets at d 6.95 and d 6.97 were due to C5 and C5’
protons. The four-proton multiplet between d 7.11–7.50 was due to C7, C7’, C8, C8’ pro-
tons. Two broad singlets at d 10.83 and d 11.44 were due to indole NH proton at N9-H
and N9’-H.
From the aforesaid facts it was concluded that the Schiff base formation was taking
place by both amino groups of ethylenediamine with two moles of 6-methyl-1-oxo-1,2,3,4-
-tetrahydrocarbazole (1a) instead of the expected Mannich reaction. The reaction was ge-
neralized for other 1-oxo-1,2,3,4-tetrahydrocarbazole derivatives (1b–e).
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1 and 2 a: R1 = R1' = CH3, R2 = R2' =R3 = R3' = H
b: R2 = R2' = CH3, R1 = R1' = R3 = R3' = H
c: R3 = R3' = CH3, R1 = R1' = R2 = R2' = H
d: R1 = R1' = Cl, R2 = R2' = R3 = R3' = H














1 and 3 a: R1 = CH3, R2 = R3 = H
b: R2 = CH3, R1 = R3 = H
c: R3 = CH3, R1 = R2 = H
d: R1 = Cl, R2 = R3 = H




In the second trial, after replacing ethylenediamine by ethanolamine under the
same conditions, product 3a was formed. Its IR spectrum (Table II) showed a band be-
tween 3430 and 3300 cm–1 for OH and NH stretching vibrations. A strong vibration at
1600 cm–1 was due to C=N stretching. Its 1H NMR spectrum (Table II) showed the pres-
ence of a methyl group as a singlet at d 2.39. The multiplets between d 2.24–2.53 and d
2.81–3.78 showed the presence of twenty two protons, including methylene protons and
NH protons. A singlet at d 4.40 was due to the OH proton. Two doublets (J = 8.44 Hz) be-
tween d 7.12–7.17 and d 7.25–7.30 were due to C7 and C8 protons. A singlet at d 7.44 was
due to C5 proton. A broad singlet at d 11.40 was due to the indole NH proton at N9-H.
The mass spectrum showed the molecular ion (m/z) at 358 (28%). Major fragmentation
peaks appeared at 357 (100%), 356 (76%), 212 (44%), 211 (86%), 210 (34%), 182 (33%), 88
(47%), 74 (27%) and 43 (42%). The fragment ions that appeared at 88 (47%) and 74 (27%)
showed the presence of =N-CH2CH2OCH2CH2NH2 and –CH2NHCH2CH2OH groups,
respectively. Also, the absence of the fragment ion at 117 confirmed the absence of
–CHNHCH2CH2OCH2CH2NH2.
The formation of compound 3 from 1-oxo-1,2,3,4-tetrahydro carbazole (1) upon re-
action with paraformaldehyde and ethanolamine is rather surprising. It was considered
worthwhile to gain an insight into the mechanistic aspects of this intriguing result. It is
reasonable to assume that the Mannich reaction of carbazole derivative 1 with para-
formaldehyde and ethanolamine afforded the expected 2-[(2-hydroxyethylamino)-me-
thyl]-1-oxo-1,2,3,4-tetrahydro carbazole. However, our attempt to isolate the compound
2-[(2-hydroxyethylamino)-methyl]-1-oxo-1,2,3,4-tetrahydro carbazole was unsuccessful.
Surprisingly, in situ condensation between 2-[(2-hydroxyethylamino)-methyl]-1-oxo-1,2,3,4-
-tetrahydro carbazole and ethanolamine resulted in the formation of product 3. The ge-
nerality was tested for other carbazole derivatives (1b–e).
Antibacterial and antifungal activities of all the newly prepared compounds against
four bacteria and four fungi are presented in Table III. The antibacterial activity of com-
pound 2d is quite good. Out of the four tested bacteria it is as active as the standard,
ciprofloxacin, against S. aureus, P. aeruginosa and B. subtilis. It also exhibited moderate
activity against E. coli. Similarly, compound 3d exhibited good results against S. aureus
and B. subtilis, moderate activity against E. coli and P. aeruginosa. In the case of compo-
und 2a, it is active against B. subtilis. Its activity against the other three bacteria is also
considerable. Compound 3a elicited moderate activity against all the tested bacteria. The
other compounds were found to have lower activity than ciprofloxacin.
In an earlier report (15) it was found that the C-6 substituted carbazole derivatives
showed enhanced pharmacological properties. Similarly, compounds 2a and 3a, having
the methyl group as substituent at C-6 position, exhibit better activities than their C-7
and C-8 counterparts. Also compounds 2d and 3d having the chloro group as substi-
tuent at C-6 position exhibited more pronounced activities than other compounds.
The antifungal activity studies showed that the activity of compound 2d against C.
albicans and F. oxysporum is on a par with the standard, carbendazim. It is also modera-
tely active against A. macrospora. Compound 3d is as active as the standard against C.
albicans and A. niger and moderately active against A. macrospora. The activity of 2a
against A. niger is quite good and considerable against A. macrospora. The other com-
pounds showed lower activity towards all the fungal species tested.
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From the above observations, the antimicrobial activities of compounds 2d and 3d
are rather good against all the tested bacteria and fungi. As far as the chemical structure
of active compounds is concerned, it is pertinent to mention here that compounds 2a
and 3a having the methyl group as substituent at the C-6 position exhibit better activi-
ties against their C-7 (2b and 3b) and C-8 (2c and 3c) counterparts. On replacing the C-6
methyl group by the C-6 chloro group (compounds 2d and 3d) even more pronounced
activity against all the tested microbial than that of their methyl analogs was achieved.
CONCLUSIONS
All the prepared compounds were well characterized using their spectral results.
Perusal of the antibacterial and antifungal results revealed that the compounds having
the methyl group as substituent at the C-6 position are active against the tested bacteria
and fungi. Also, compounds having the chloro group as substituent at C-6 position ex-
hibited better activity than their methyl counterparts. Considering the structures of the
standard ciprofloxacin and carbendazim, it was concluded that, to further enhance the
activity of thus synthesized compounds 2a, 3a, 2d and 3d, attempts to introduce groups
like fluoro, carboxylic acid, cyclopropyl and piperazine should be carried out.
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S A @ E T A K
Sinteza, karakterizacija i antimikrobni u~inak derivata karbazola
ARPUTHARAJ EBENEZER MARTIN i KARNAM JAYARAMPILLAI RAJENDRA PRASAD
Reakcijom 1-okso-1,2,3,4-tetrahidrokarbazola (1a–e) s paraformaldehidom i etilen-
diaminom dobiveni su N,N’-bis(1,2,3,4-tetrahidrokarbazol-1-iliden)etan-1,2-diamini (2a–e).
Ovdje su, kao i u drugim sli~nim poku{ajima zamjene etilendiamina etanolaminom, nas-
tali derivati 2-{[1-(2-(2-aminoetoksi)etilimino)-1,2,3,4-tetrahidrokarbazol-2-il-metil]amino}-
etanola (3a–e). Spojevi su karakterizirani pomo}u IR, 1H NMR i masenom spektromet-
rijom, te elementarnom analizom. Ispitano je antibakterijsko i antimikotsko djelovanje
produkata 2a–e i 3a–e. Spojevi sa supstituentima na polo`aju C-6 imaju izra`eno anti-
mikrobno djelovanje.
Klju~ne rije~i: 1-okso-1,2,3,4-tetrahidrokarbazoli, paraformaldehid, etilendiamin, etanolamin, N,N’-
-bis(1,2,3,4-tetrahidrokarbazol-1-iliden)etan-1,2-diamin, 2-{[1-(2-(2-aminoetoksi)etilimino)-1,2,3,4-tet-
rahidrokarbazol-2-il-metil]-amino}etanol, antibakterijsko i antimikotsko djelovanje
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